Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Am J Kidney Dis
    March 2024
  1. HONDA D, Okunaga I, Omote D, Inoue H, et al
    Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
    >> Share

    February 2024
  2. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    >> Share

    January 2024
  3. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    >> Share

  4. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    >> Share

  5. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    >> Share

  6. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    >> Share

    December 2023
  7. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    >> Share

  8. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    >> Share

  9. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    >> Share

    September 2023
  10. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    >> Share

  11. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    >> Share

  12. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    >> Share

  13. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    >> Share

  14. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    >> Share

    April 2023
  15. CERVANTES CE, Bloch EM, Sperati CJ
    Therapeutic Plasma Exchange: Core Curriculum 2023.
    Am J Kidney Dis. 2023;81:475-492.
    >> Share

    December 2022
  16. GENEST DS, Patriquin CJ, Licht C, John R, et al
    Renal Thrombotic Microangiopathy: A Review.
    Am J Kidney Dis. 2022 Dec 9:S0272-6386(22)01056.
    >> Share

  17. CANNEY M, Gunning HM, Zheng Y, Rose C, et al
    The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Am J Kidney Dis. 2022;80:740-750.
    >> Share

    November 2022
  18. KUANG H, Liu J, Jia XY, Cui Z, et al
    Autoimmunity in Anti-Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy.
    Am J Kidney Dis. 2022 Nov 2. pii: S0272-6386(22)00855.
    >> Share

    October 2022
  19. JAVAUGUE V, Said SM, Bu L, Bridoux F, et al
    Prognostic Value of Diffuse Crescentic Lesions in Fibrillary Glomerulonephritis.
    Am J Kidney Dis. 2022 Oct 10. pii: S0272-6386(22)00927.
    >> Share

    September 2022
  20. SAHA MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, et al
    Glomerular Hematuria and the Utility of Urine Microscopy: A Review.
    Am J Kidney Dis. 2022;80:383-392.
    >> Share

  21. YU X, Chen N, Xue J, Mok CC, et al
    Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
    Am J Kidney Dis. 2022 Sep 1. pii: S0272-6386(22)00860.
    >> Share

    August 2022
  22. KUDOSE S, Batal I, Lucia J, Patel P, et al
    Proliferative Glomerulonephritis With Hidden Monotypic IgG3kappa Deposits: A Case Report.
    Am J Kidney Dis. 2022 Aug 2. pii: S0272-6386(22)00822.
    >> Share

    July 2022
  23. MARLAIS M, Wlodkowski T, Printza N, Kronsteiner D, et al
    Clinical Factors and Adverse Kidney Outcomes in Children With ANCA-Associated Glomerulonephritis.
    Am J Kidney Dis. 2022 Jul 7. pii: S0272-6386(22)00772.
    >> Share

    June 2022
  24. LIANG KV, Ellis BK, Stokes MB, Smith RJ, et al
    Hematuria and Proteinuria in a Patient With Recurrent Pulmonary Illnesses: A Quiz.
    Am J Kidney Dis. 2022;79:A13-A15.
    >> Share

    April 2022
  25. KANT S, Kronbichler A, Sharma P, Geetha D, et al
    Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
    Am J Kidney Dis. 2022;79:582-600.
    >> Share

    March 2022
  26. LUO J, Yuan Y, Tian J, Zhou Z, et al
    Clinicopathological Characteristics and Outcomes of PLA2R-Associated Membranous Nephropathy in Seropositive Patients Without PLA2R Staining on Kidney Biopsy.
    Am J Kidney Dis. 2022 Mar 11. pii: S0272-6386(22)00528.
    >> Share

    February 2022
  27. ROVIN BH
    Kidney Failure in Systemic Lupus Erythematosus: A Fraught Complication in a Fraught Disease.
    Am J Kidney Dis. 2022 Feb 3. pii: S0272-6386(21)01044.
    >> Share

    December 2021
  28. TANG X, VanBeek C, Haas M, Cook HT, et al
    Cell-Mediated Glomerulonephritis Without Immune Complexes in Native Kidney Biopsies: A Report of 7 Cases.
    Am J Kidney Dis. 2021 Dec 30. pii: S0272-6386(21)01050.
    >> Share

    November 2021
  29. DERNER O, Kramer A, Hruskova Z, Arici M, et al
    Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.
    Am J Kidney Dis. 2021 Nov 6. pii: S0272-6386(21)00954.
    >> Share

  30. FENAROLI P, Rossi GM, Angelotti ML, Antonelli G, et al
    Collapsing Glomerulopathy as a Complication of Type I Interferon-Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutieres Syndrome.
    Am J Kidney Dis. 2021;78:750-754.
    >> Share

    October 2021
  31. SANTORO D, Debiec H, Longhitano E, Torreggiani M, et al
    Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
    Am J Kidney Dis. 2021 Oct 29. pii: S0272-6386(21)00950.
    >> Share

  32. LIM CC, Choo J, Tan CS
    COVID-19 Vaccination in Immunoglobulin A Nephropathy.
    Am J Kidney Dis. 2021;78:617.
    >> Share

  33. SHAKOOR MT, Birkenbach MP, Lynch M
    ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.
    Am J Kidney Dis. 2021;78:611-613.
    >> Share

    September 2021
  34. NASR SH, Leung N, Said SM, Alkhateeb HB, et al
    Membranous Nephropathy With Extensive Tubular Basement Membrane Deposits Following Allogeneic Hematopoietic Cell Transplant: A Report of 5 Cases.
    Am J Kidney Dis. 2021 Sep 8. pii: S0272-6386(21)00840.
    >> Share

    August 2021
  35. IDREES N, Beck LH Jr
    Multitarget Combination Immunosuppressive Therapy for Primary Membranous Nephropathy.
    Am J Kidney Dis. 2021 Aug 28. pii: S0272-6386(21)00709.
    >> Share

  36. WASIK H, Chadha V, Galbiati S, Warady B, et al
    Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study.
    Am J Kidney Dis. 2021 Aug 27. pii: S0272-6386(21)00825.
    >> Share

  37. AMIN K, Choksi V, Farouk SS, Sparks MA, et al
    Diarrhea in a Patient With Combined Kidney-Pancreas Transplant.
    Am J Kidney Dis. 2021;78:A13-A16.
    >> Share

    July 2021
  38. PATTRAPORNPISUT P, Avila-Casado C, Reich HN
    IgA Nephropathy: Core Curriculum 2021.
    Am J Kidney Dis. 2021 Jul 9. pii: S0272-6386(21)00598.
    >> Share

    June 2021
  39. ZONOZI R, Laliberte K, Huizenga NR, Rosenthal JK, et al
    Combination of Rituximab, Low-dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
    Am J Kidney Dis. 2021 Jun 23. pii: S0272-6386(21)00690.
    >> Share

  40. RONSIN C, Georges M, Chapelet-Debout A, Augusto JF, et al
    ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
    Am J Kidney Dis. 2021 Jun 10. pii: S0272-6386(21)00637.
    >> Share

    May 2021
  41. KUKLA A, Ventura-Aguiar P, Cooper M, de Koning EJP, et al
    Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review.
    Am J Kidney Dis. 2021 May 13. pii: S0272-6386(21)00600.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016